Literature DB >> 18320741

[Mechanisms in pulmonary fibrosis].

Bruno Crestani1, Sylvain Marchand-Adam, Aurélie Fabre, Monique Dehoux, Paul Soler.   

Abstract

Despite the continuous and renewed interest in IPF, the precise biological mechanisms underlying the development of fibrosis and leading to the irreversible destruction of the lung are still unknown. Inflammation seems to play a minor role at the initiation of the disease. Identification of excessive apoptosis of alveolar epithelial cells led to the hypothesis that the disorder results from repeated alveolar epithelial cell injury and activation. In turn, alveolar epithelial cells induce the recruitment, proliferation, and activation of mesenchymal cells with the formation of fibroblastic foci and the abnormal accumulation of extracellular matrix. Fibroblastic foci are connected in a tridimensional reticulum. Circulating mesenchymal precursors called fibrocytes, and transdifferenciation of epithelial cells, endothelial cells and/or mesothelial cells, may all contribute to the accumulation of fibroblasts in the lung.

Entities:  

Mesh:

Year:  2007        PMID: 18320741

Source DB:  PubMed          Journal:  Rev Prat        ISSN: 0035-2640


  6 in total

1.  Pathological alteration of FoxO3a activity promotes idiopathic pulmonary fibrosis fibroblast proliferation on type i collagen matrix.

Authors:  Richard Seonghun Nho; Polla Hergert; Judith Kahm; Jose Jessurun; Craig Henke
Journal:  Am J Pathol       Date:  2011-09-03       Impact factor: 4.307

2.  Design and optimization of silymarin loaded in lyophilized fast melt tablets to attenuate lung toxicity induced via HgCl2 in rats.

Authors:  Nermin M Sheta; Sylvia A Boshra; Mohamed A Mamdouh; Khaled M Abdel-Haleem
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

3.  Inhibitory Effects of Astragaloside IV on Bleomycin-Induced Pulmonary Fibrosis in Rats Via Attenuation of Oxidative Stress and Inflammation.

Authors:  Wei-Na Yu; Li-Feng Sun; Hua Yang
Journal:  Inflammation       Date:  2016-10       Impact factor: 4.092

4.  Conversion of bone marrow mesenchymal stem cells into type II alveolar epithelial cells reduces pulmonary fibrosis by decreasing oxidative stress in rats.

Authors:  Kun Huang; Xiaowen Kang; Xinyan Wang; Shijie Wu; Jinling Xiao; Zhaoguo Li; Xiaomei Wu; Wei Zhang
Journal:  Mol Med Rep       Date:  2014-11-19       Impact factor: 2.952

Review 5.  Role of Farnesoid X Receptor in the Pathogenesis of Respiratory Diseases.

Authors:  Jin-Nan Wu; Jian-Rong Chen; Jin-Liang Chen
Journal:  Can Respir J       Date:  2020-11-26       Impact factor: 2.409

6.  Sodium Houttuyfonate Inhibits Bleomycin Induced Pulmonary Fibrosis in Mice.

Authors:  Yun-Hui Shen; Ming-Han Cheng; Xin-Yu Liu; De-Wei Zhu; Jian Gao
Journal:  Front Pharmacol       Date:  2021-02-25       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.